Role Of Surgical Lung Biopsy Research Articles

Pulmonary Amyloidoma: A Case Report and Brief Review of the Literature.

We report the case of a 59-year-old female patient, a former smoker, who was diagnosed with bilateral pulmonary nodules. Extensive medical investigations were conducted, including a surgical lung biopsy, which led to the diagnosis of pulmonary amyloidoma. The diagnostic process was guided by the presence of a persistent, polymorphic, and nonspecific clinical picture, strengthened by imaging findings characterized by mixed nodular lesions and the addition of interstitial involvement, along with partial deterioration of the pulmonary parenchyma architecture. Although it is recognized as a benign tumor, pulmonary amyloidoma requires special care in order to rule out systemic involvement, association with lymphomas, or systemic amyloidosis. This case highlights the comprehensive investigations required in the presence of multiple pulmonary nodules and the wide range of possible diagnoses. It underscores the pivotal role of surgical lung biopsy and histopathological examination. The case is instructive, addressing a rare pathology, on the border between specialties, while also emphasizing potential evolving challenges and providing further insights into the clinical course of this disease.

The Role of Surgical Lung Biopsy in the Diagnosis of Fibrotic Interstitial Lung Disease: Perspective from the Pulmonary Fibrosis Foundation.

Diagnosis of interstitial lung disease (ILD) requires a multidisciplinary discussion approach that includes clinicians, radiologists, and pathologists. Surgical lung biopsy (SLB) is currently the recommended standard in obtaining pathologic specimens for patients with ILD requiring a tissue diagnosis. The increased diagnostic confidence and accuracy provided by microscopic pathology assessment of SLB specimens must be balanced with the associated risks in patients with ILD. This document was developed by the SLB Working Group of the Pulmonary Fibrosis Foundation, composed of a multidisciplinary group of ILD physicians, including pulmonologists, radiologists, pathologists, and thoracic surgeons. In this document, we present an up-to-date literature review of the indications, contraindications, risks, and alternatives to SLB in the diagnosis of fibrotic ILD; outline an integrated approach to the decision-making around SLB in the diagnosis of fibrotic ILD; and provide practical information to maximize the yield and safety of SLB.

Video-Assisted Thoracoscopic Lung Biopsy in Critically Ill Patients With Hematologic Malignancy and Acute Respiratory Distress Syndrome: A Case Series Report.

Pulmonary complications are prevalent among patients with hematologic malignancies, who are at high risk of developing acute respiratory distress syndrome (ARDS). Although diffuse alveolar damage is considered the diagnostic hallmark of ARDS, there are plenty of other non–diffuse alveolar damage etiologies that can mimic ARDS and benefit from a specific therapy, therefore correcting the underlying cause. When the etiology remains unclarified despite noninvasive procedures, a surgical lung biopsy (either open via thoracotomy or video-assisted thoracoscopic surgery [VATS]) may be warranted. However, the role of surgical lung biopsy has not been extensively studied in patients with hematologic malignancy and ARDS and so doubt exists about the risk-benefit relationship of such procedures. In this article, we report a series of 8 critically ill patients with hematologic malignancies and ARDS, who underwent VATS lung biopsy, in a specialized institution in Cali, Colombia, from 2015 to 2019, with special emphasis on its diagnostic yield, modifications in treatment protocol, and safety. VATS lung biopsy is a minimally invasive procedure that appears to be a relatively safe with few postoperative complications and minimal perioperative mortality. It has a high diagnostic yield, resulting in a modification of treatment in a nondepreciable percentage of patients. However, this subset of patients was critically ill, with a high risk of mortality, and the lung biopsy did not appear to affect in this aspect. Future randomized controlled trials are needed to further clarify this topic.

Surgical lung biopsy for the management of diffuse interstitial lung disease

To evaluate the role of surgical lung biopsy (SLB) in the management of diffuse interstitial lung disease (DILD) with no specific diagnosis. We conducted a retrospective analysis of 179 cases with DILD of non-specific diagnosis after non-invasive methods and minimally invasive processes, including bronchoscopy and CT-guided lung biopsy, were performed SLB at Peking Union Medical College Hospital between 2006 and 2012. Patient demographics, surgical approach, number and site of biopsies, post-operative complications and postoperative pathological diagnosis and treatment were analyzed. Of 179 cases, there were 91 males (50.8%) and 88 females (49.2%), with a median age of 47.3 years (range 16-76). There were 6 cases(3.4%) who were younger than 20 years and 25 cases(14%) older than 60 years. From 2006 to 2012, every year there were 16 case (8.9%), 17 cases(9.5%), 19 cases (10.6%), 44 cases (24.6%), 33 cases(18.4%), 31 cases (17.3%) and 19 cases (10.6%) respectively. The total median hospital stay was 33.4 days (range 6-76) and the mean postoperative stay was 18.6 days (range 2-56). The mean duration for chest drainage was 3.2 days (range 2-18). Among them, 150 cases were arranged with video-assisted thoracoscopy surgery (VATS) and 29 cases were arranged with minithoracotomy. The number of biopsies taken was ranged from one to four and there were 126 cases (70.4%) had more than one biopsy. The biopsy was performed in left lingular lobe (54 cases/30.2%), left natural upper lobe (16 cases/8.9%), left inferior basal segments (56 cases/31.3%), right upper lobe (30 cases/16.7%), right meddle lobe (40case/22.3%) and right inferior basal segments (56 case/31.3%) respectively. Definitive pathological diagnosis was reached in 103 cases (57.5%), diagnosis was reached after combination of pathological, clinical and radiological manifestations in 32 cases (17.9%) and there were 44 cases (24.6%) could not achieved diagnosis even after the SLB. Chronic extrinsic allergic alveolitis was the most common diagnosis (33/24.4%), following nonspecific interstitial pneumonia (27/20%) for the 135 cases with a definite diagnosis. Among 179 cases, there were 114 cases had a change in their treatment following the results of SLB. There were 16 cases had a fever after surgery and antibiotics were administrated for eleven of them. Other complication were included delayed wound healing (>10 days after surgery, 6 cases), thoracic hemorrhage (5 cases), chest tube re-indwelling because of pneumothorax (4 cases), delayed weaning of ventilator (>3 days after surgery, 4 cases), respiratory failure (3 cases), and thoracic infection (2 cases). There were two cases died within 30 days following surgery because of respiratory failure. Most of the DILD patients who were arranged with SLB were young and middle-aged cases. The left lingular lobe, right meddle lobe and both inferior lobes were the preferred biopsy sites. The results of biopsy surgery could provides a diagnosis for most of the DILD patients and could modulate the treatment for more than half of them. Fever and delayed wound healing were the major complications. The SLB related mortality was low. SLB was suggested to the undiagnosed DILD patients.

Chronic Eosinophilic Pneumonia: A Pediatric Case with Idiopathic Bronchiectasis.

Chronic eosinophilic pneumonia (CEP) is a rare lung disease and is especially uncommon in children. It presents with subacute respiratory symptoms of hypoxemia and dyspnea, peripheral infiltrates on imaging, and eosinophilia. However, it can be difficult to diagnose, as there is no strict diagnosis criteria and the clinical findings may be very nonspecific. In this case report, we describe a 14-year-old female with an unusual presentation of asymptomatic bronchiectasis, and the role of surgical lung biopsy in the diagnosis of CEP when no peripheral or alveolar eosinophilia is seen. It suggests that perhaps bronchiectasis can also be an unusual presenting sign of CEP and that there may be more asymptomatic cases of CEP with the true incidence being underreported, especially in the pediatric population.

The role of surgical lung biopsy in the management of interstitial lung disease: experience from a single institution in the UK

Interstitial lung disease (ILD) includes a wide spectrum of pulmonary pathologies. The role of surgical lung biopsy (SLB) in the diagnosis of ILD is still controversial. The purpose of this study was to ascertain whether SLB is worthwhile in the management of ILD. One hundred and three patients underwent SLB for ILD from April 2008 to March 2010 at a single institution. Outcomes included patient demographics, preoperative investigations, preoperative diagnosis and treatment, surgical approach, number and site of biopsies, complications, length of postoperative stay and postoperative pathological diagnosis and treatment. Fifty-one (49.6%) patients were male and 52 (50.4%) were female. The median age was 58 (range 26-78). Major complications were seen in 7 patients (6.8%). Five patients (4.9%) died within 30 days following surgery. Definitive pathological diagnosis (DPD) was reached in 72 (69.9%) patients, whereas no DPD was achieved in 31 (30.1%). Within the group of patients who received DPD, this differed from the clinical diagnosis in 53 patients (51.5%), and was concordant in 19 (18.4%). The DPD was helpful in guiding the management of 47 patients (45.6%), who had a change in their treatment following the procedure. The median hospital stay was 4 days (range 2-42 days). SLB is a well-recognized procedure. Although it provides a diagnosis for the majority of patients, in our series SLB was inconclusive in a considerable number of cases and did not lead to a therapeutic change for more than half of all patients. Furthermore, SLB is not without risk and can be associated with a prolonged hospital stay. We believe that SLB should be performed in a select group of patients with ILD after discussion by a multidisciplinary panel.

Hypersensitivity Pneumonia: Role of Surgical Lung Biopsy

Lung biopsy often plays a key role in identifying patients with hypersensitivity pneumonia, especially in the absence of a typical history. A 69-year-old woman with a 2-year history of unexplained dyspnea on exertion underwent surgical lung biopsy for diagnosis of diffuse lung disease thought to represent idiopathic pulmonary fibrosis. Her biopsy showed honeycomb change and fibroblast foci suggestive of usual interstitial pneumonia, but also showed areas of cellular interstitial pneumonia with chronic bronchiolitis and a pattern of granulomatous inflammation typical of hypersensitivity pneumonia. The classic features of hypersensitivity pneumonia in surgical lung biopsy are emphasized, including a bronchiolocentric cellular interstitial pneumonia, chronic bronchiolitis, and poorly formed nonnecrotizing granulomas. As illustrated in our patient, sometimes subtle histologic clues are key in separating hypersensitivity pneumonia from usual interstitial pneumonia and other forms of idiopathic interstitial pneumonia. Making the distinction is important given differences in treatment strategies and natural history.

The role of surgical lung biopsy in the management of undefined parenchymal lung disease

The role of surgical lung biopsy in the management of undefined parenchymal lung disease

High Resolution Computed Tomography in Idiopathic Interstitial Pneumonias

In June 2001, using an "international multidisciplinary consensus," the American Thoracic Society and European Respiratory Society classified the idiopathic interstitial pneumonias (Am J Respir Crit Care Med 2002;165:277-304). The American Thoracic Society and European Respiratory Society coined the term idiopathic interstitial pneumonias because the diseases in question have both unknown etiologies and various combinations of inflammation and fibrosis within the lung parenchyma. The consensus included the development of a classification standard of the interstitial pneumonias and discussed the role of surgical lung biopsy and bronchoalveolar lavage evaluation. The classification of idiopathic interstitial pneumonias is based on histologic criteria, which correlate to imaging patterns on high-resolution computed tomography. The group of lung diseases under the umbrella of idiopathic interstitial pneumonias includes the following: usual interstitial pneumonia, nonspecific interstitial pneumonia, desquamative interstitial pneumonia, respiratory bronchiolitis interstitial lung disease, acute interstitial pneumonia, cryptogenic organizing pneumonia, and lymphoid interstitial pneumonia.

Role of Surgical Lung Biopsy in Separating Chronic Hypersensitivity Pneumonia From Usual Interstitial Pneumonia/Idiopathic Pulmonary Fibrosis

Role of Surgical Lung Biopsy in Separating Chronic Hypersensitivity Pneumonia From Usual Interstitial Pneumonia/Idiopathic Pulmonary Fibrosis

Beyond a consensus classification for idiopathic interstitial pneumonias: progress and controversies

Histopathological classification schemes provide the underpinnings for separating idiopathic interstitial pneumonias into clinically meaningful groups. An interdisciplinary classification system based on a combination of evidence and expert opinion was published in 2002 and set the stage for controversy in several areas, including not only nomenclature but also the role of surgical lung biopsy and pathologists in diagnosis. We provide a brief overview of the clinical and histological features of the idiopathic interstitial pneumonias, and focus on selected topics of interest that have emerged in recent years.

Diagnosis: To Biopsy or Not to Biopsy: Assessing the Role of Surgical Lung Biopsy in the Diagnosis of Idiopathic Pulmonary Fibrosis

Idiopathic pulmonary fibrosis (IPF) is a chronic disorder that is associated with a poorer prognosis than subacute idiopathic interstitial pneumonias (IIPs). IPF can be differentiated from other IIPs on the basis of its histologic pattern of usual interstitial pneumonia (UIP). Although a surgical lung biopsy specimen showing a UIP pattern is required for the definitive diagnosis of IPF, clinical criteria can be used in the absence of a lung biopsy specimen to make a likely diagnosis of IPF. The predictive value of these criteria largely depends on the expertise of the clinician and radiologist, but considerable interobserver variability exists even when evaluations are performed by experts in the field. Moreover, these criteria lead to misdiagnosis in about 25 to 35% of cases. Interobserver variability is reduced and diagnostic accuracy is improved in cases in which a diagnosis is made with a high degree of confidence. Diagnostic accuracy is also higher when the diagnosis is made by a core group of experts rather than by a referring center. The decision on whether or not to perform a surgical lung biopsy is difficult. It is clearly indicated in cases in which clinical or radiologic findings are atypical or when the diagnosis is made with a low degree of certainty.

Safety of Surgical Lung Biopsy in Suspected Idiopathic Pulmonary Fibrosi

PURPOSE: Controversy exists regarding the role of surgical lung biopsy (SLB) in suspected idiopathic pulmonary fibrosis (IPF). The clinician's decision to refer patients for SLB incorporates an estimate of the risk of this procedure. To better gauge the risk of SLB, we examined postoperative outcomes for patients undergoing SLB for interstitial lung disease (ILD).